Cargando…
Clinical trials of immunotherapy in triple-negative breast cancer
PURPOSE: Immunotherapy has started to transform the treatment of triple-negative breast cancer (TNBC), in part due to the unique immunogenicity of this breast cancer subtype. This review summarizes clinical studies of immunotherapy in advanced and early-stage TNBC. FINDINGS: Initial studies of check...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338129/ https://www.ncbi.nlm.nih.gov/pubmed/35834065 http://dx.doi.org/10.1007/s10549-022-06665-6 |